New study tackles dual challenge of HIV and cancer care in zimbabwe

NCT ID NCT06934369

Recruiting now Knowledge-focused Sponsor: Fred Hutchinson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how to help people with both HIV and cancer stay engaged in their HIV care while receiving cancer treatment. Researchers will first observe 150 patients to identify barriers, then develop and test strategies to improve care. A second group of 150 patients will be studied after the strategies are put in place to see if they help.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to help people with both HIV and cancer stay on their HIV treatment while undergoing cancer therapy.
What could go wrong: This is an early-stage observational and development study, not a clinical trial of a new drug. The strategies may not work as hoped or may be difficult to implement widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer HIV infectious disease neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER HIV

Contacts and locations

Show contact details

Locations

Parirenyatwa Hospital
RECRUITING

Harare, Zimbabwe

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.